|
Q |
Emca1 |
Estrogen-induced mammary cancer QTL 1 |
|
IDA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr 5:99,216,724...148,607,142
|
|
Q |
Emca10 |
Estrogen-induced mammary cancer QTL 10 |
|
IDA |
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr 6:16,536,140...61,536,140
|
|
Q |
Emca11 |
Estrogen-induced mammary cancer QTL 11 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:99,753,548...113,061,097
|
|
Q |
Emca12 |
Estrogen-induced mammary cancer QTL 12 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:124,160,767...133,749,643
|
|
Q |
Emca13 |
Estrogen-induced mammary cancer QTL 13 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:9,823,266...99,753,708
|
|
Q |
Emca2 |
Estrogen-induced mammary cancer QTL 2 |
|
IDA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr18:18,007,599...63,571,040
|
|
Q |
Emca4 |
Estrogen-induced mammary cancer QTL 4 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:62,004,452...101,773,158
|
|
Q |
Emca5 |
Estrogen-induced mammary cancer QTL 5 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:43,827,364...169,034,231
|
|
Q |
Emca6 |
Estrogen-induced mammary cancer QTL 6 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 4:44,463,720...155,883,716
|
|
Q |
Emca7 |
Estrogen-induced mammary cancer QTL 7 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 6:15,107,216...107,351,382
|
|
Q |
Emca8 |
Estrogen-induced mammary cancer QTL 8 |
|
IDA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 5:50,328,551...141,643,988
|
|
Q |
Mamtr1 |
Mammary tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:12844486 |
RGD:631852 |
NCBI chr 5:12,789,751...113,558,310
|
|
Q |
Mamtr2 |
Mammary tumor resistance QTL 2 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:7,887,772...12,654,247
|
|
Q |
Mamtr3 |
Mammary tumor resistance QTL 3 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:32,373,770...43,665,178
|
|
Q |
Mamtr4 |
Mammary tumor resistance QTL 4 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:16,491,740...61,491,740
|
|
Q |
Mamtr5 |
Mammary tumor resistance QTL 5 |
|
IDA |
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr 5:18,873,947...63,873,947
|
|
Q |
Mamtr6 |
Mammary tumor resistance QTL 6 |
|
IDA |
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr18:19,278,901...83,218,561
|
|
Q |
Mamtr7 |
Mammary tumor resistance QTL 7 |
|
IDA |
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr10:9,658,275...104,670,812
|
|
Q |
Mamtr8 |
Mammary tumor resistance QTL 8 |
|
IDA |
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr18:31,359,408...83,218,561
|
|
Q |
Mcs1 |
Mammary carcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:8168109 |
RGD:61080 |
NCBI chr 2:7,887,772...23,319,447
|
|
Q |
Mcs12 |
Mammary carcinoma susceptibility QTL 12 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:58,973,449...60,051,321
|
|
Q |
Mcs13 |
Mammary carcinoma susceptibility QTL 13 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:63,190,890...69,927,503
|
|
Q |
Mcs14 |
Mammary carcinoma susceptibility QTL 14 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:76,369,776...80,813,390
|
|
Q |
Mcs15 |
Mammary carcinoma susceptibility QTL 15 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr10:85,565,469...103,884,409
|
|
Q |
Mcs16 |
Mammary carcinoma susceptibility QTL 16 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr 1:2,244,390...43,433,040
|
|
Q |
Mcs17 |
Mammary carcinoma susceptibility QTL 17 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr 1:197,670,404...242,670,404
|
|
Q |
Mcs18 |
Mammary carcinoma susceptibility QTL 18 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr 2:7,887,772...42,804,738
|
|
Q |
Mcs19 |
Mammary carcinoma susceptibility QTL 19 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr 5:99,485,997...103,690,167
|
|
Q |
Mcs2 |
Mammary carcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 7:19,032,807...35,526,300
|
|
Q |
Mcs20 |
Mammary carcinoma susceptibility QTL 20 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr 9:13,533,770...42,791,750
|
|
Q |
Mcs21 |
Mammary carcinoma susceptibility QTL 21 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr10:28,875,650...52,200,160
|
|
Q |
Mcs22 |
Mammary carcinoma susceptibility QTL 22 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr18:52,539,763...63,933,058
|
|
Q |
Mcs23 |
Mammary carcinoma susceptibility QTL 23 |
|
IDA |
|
RGD |
PMID:17404222 |
RGD:1601189 |
|
|
Q |
Mcs24 |
Mammary carcinoma susceptibility QTL 24 |
|
IDA |
|
RGD |
PMID:17404222 |
RGD:1601189 |
NCBI chr 5:64,719,390...109,719,390
|
|
Q |
Mcs25 |
Mammary carcinoma susceptibility QTL 25 |
|
IDA |
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:10,894,415...110,548,006
|
|
Q |
Mcs26 |
Mammary carcinoma susceptibility QTL 26 |
|
IDA |
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:106,752,656...132,339,866
|
|
Q |
Mcs27 |
Mammary carcinoma susceptibility QTL 27 |
|
IDA |
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr13:43,437,904...47,841,255
|
|
Q |
Mcs28 |
Mammary carcinoma susceptibility QTL 28 |
|
IDA |
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:77,743,239...78,039,084
|
|
Q |
Mcs29 |
Mammary carcinoma susceptibility QTL 29 |
|
IDA |
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:77,816,155...77,988,860
|
|
Q |
Mcs3 |
Mammary carcinoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 1:102,268,556...147,268,556
|
|
Q |
Mcs30 |
Mammary carcinoma susceptibility QTL 30 |
|
IDA |
|
RGD |
PMID:24023717 |
RGD:7327193 |
NCBI chr12:797,729...8,525,593
|
|
Q |
Mcs31 |
Mammary carcinoma susceptibility QTL 31 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 9:77,813,894...111,552,878
|
|
Q |
Mcs32 |
Mammary carcinoma susceptibility QTL 32 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 1:115,540,693...238,914,717
|
|
Q |
Mcs33 |
Mammary carcinoma susceptibility QTL 33 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 5:131,345,754...166,875,058
|
|
Q |
Mcs34 |
Mammary carcinoma susceptibility QTL 34 |
|
IDA |
|
RGD |
PMID:23967281 |
RGD:7794780 |
|
|
Q |
Mcs4 |
Mammary carcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 8:16,290,444...61,290,444
|
|
Q |
Mcs5 |
Mammary carcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 5:55,805,606...132,207,589
|
|
Q |
Mcs6 |
Mammary carcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 7:26,737,401...63,902,784
|
|
Q |
Mcs7 |
Mammary carcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr10:72,224,939...107,211,142
|
|
Q |
Mcs8 |
Mammary carcinoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr14:3,813,074...24,531,477
|
|
Q |
Mcsm1 |
Mammary carcinoma susceptibility modifier QTL 1 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 6:58,632,962...103,632,962
|
|
|
Q |
Prcr1 |
Prostate cancer resistance QTL 1 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 2:72,532,993...157,142,209
|
|
Q |
Prcr2 |
Prostate cancer resistance QTL 2 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 1:20,763,158...44,095,856
|
|
Q |
Prcs1 |
Prostate cancer susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr19:15,114,598...34,521,833
|
|
Q |
Prcs2 |
Prostate cancer susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr20:4,606,607...17,617,956
|
|
|
Q |
Inf1 |
Infertility severity QTL 1 |
|
IDA |
|
RGD |
PMID:10615258 |
RGD:631224 |
NCBI chr 8:22,662,330...67,662,330
|
|
|
Q |
Tescar1 |
Testicular tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr11:1,041,931...66,113,562
|
|
|
Q |
Teswt1 |
Testicular weight QTL 1 |
|
IDA |
|
RGD |
PMID:16651691 |
RGD:1625009 |
NCBI chr 7:80,221,299...94,811,326
|
|
Q |
Teswt2 |
Testicular weight QTL 2 |
|
IDA |
|
RGD |
PMID:16651691 |
RGD:1625009 |
NCBI chr 1:197,697,768...238,755,659
|
|
|
Q |
Eutr1 |
Estrogen induced uterine response QTL 1 |
|
IDA |
|
RGD |
PMID:16284801 |
RGD:1559292 |
NCBI chr 5:2,138,965...166,875,058
|
|
Q |
Eutr2 |
Estrogen induced uterine response QTL 2 |
|
IDA |
|
RGD |
PMID:16284802 |
RGD:1559291 |
NCBI chr 5:34,730,116...104,251,008
|
|
|
Q |
Edcs1 |
Endometrial carcinoma susceptibility QTL1 |
|
IDA |
update to integrity trait |
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr11:18,976,208...24,697,116
|
|
Q |
Edcs2 |
Endometrial carcinoma susceptibility QTL2 |
|
IDA |
update to integrity trait |
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr12:6,833,190...17,870,186
|
|
Q |
Edcs3 |
Endometrial carcinoma susceptibility QTL3 |
|
IDA |
update to integrity trait |
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr20:1...25,159,026
|
|
Q |
Edcs4 |
Endometrial carcinoma susceptibility QTL 4 |
|
IDA |
update to integrity trait |
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr 1:206,081,677...251,081,677
|
|
Q |
Edcs5 |
Endometrial carcinoma susceptibility QTL 5 |
|
IDA |
update to integrity trait |
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr17:57,246,723...70,852,846
|
|